FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065431672> ?p ?o ?g. }

• W2065431672 endingPage "161" @default.
• W2065431672 startingPage "154" @default.
• W2065431672 abstract "For more than 5 decades, warfarin has been the mainstay of therapy when oral anticoagulation is required. It has been shown to be effective in the prevention as well as treatment of various thromboembolic disorders. However, drawbacks of warfarin, such as time-consuming requirements for frequent international normalized ratio monitoring, as well as drug and food interactions, have encouraged the development of alternative oral agents. One such agent, dabigatran, has risen up to the challenge. Due to its predictable anticoagulation response, dabigatran does not require routine anticoagulation monitoring. Another advantage dabigatran has over warfarin is its more favorable drug and food interaction profiles. Dabigatran was shown to be noninferior to warfarin in studies evaluating the prevention of stroke and systemic embolism in patients with atrial fibrillation, thus leading to the US Food and Drug Administration approval for this indication. Dabigatran has also demonstrated efficacy in the prevention of venous thromboembolism in patients undergoing total hip or knee replacement surgery as well as the prevention of recurrent venous thromboembolism, although these are not current Food and Drug Administration-approved indications. The safety profile appears to be similar to warfarin with regards to overall bleeding risk, though the risk for gastrointestinal bleeds was higher in patients on dabigatran 150 mg twice daily. Disadvantages of dabigatran may include a higher frequency of dyspepsia compared with warfarin, lack of dosing information in severe renal impairment, possible missed opportunities for periodic health examinations and interventions due to elimination of regular physician's visit for international normalized ratio monitoring, and drug costs. This article provides an overview of the clinical studies, pharmacokinetic profile, adverse effects, drug interactions as well as advantages and disadvantages associated with dabigatran." @default.
• W2065431672 created "2016-06-24" @default.
• W2065431672 creator A5002697588 @default.
• W2065431672 creator A5009134798 @default.
• W2065431672 date "2011-05-01" @default.
• W2065431672 modified "2023-10-17" @default.
• W2065431672 title "Dabigatran Etexilate" @default.
• W2065431672 cites W1531871815 @default.
• W2065431672 cites W1967889750 @default.
• W2065431672 cites W1983866419 @default.
• W2065431672 cites W2000438765 @default.
• W2065431672 cites W2006632121 @default.
• W2065431672 cites W2017922054 @default.
• W2065431672 cites W2019561783 @default.
• W2065431672 cites W2022932023 @default.
• W2065431672 cites W2027863730 @default.
• W2065431672 cites W2035728361 @default.
• W2065431672 cites W2052478023 @default.
• W2065431672 cites W2062946016 @default.
• W2065431672 cites W2075352627 @default.
• W2065431672 cites W2113446992 @default.
• W2065431672 cites W2115348966 @default.
• W2065431672 cites W2118092611 @default.
• W2065431672 cites W2124882231 @default.
• W2065431672 cites W2136489990 @default.
• W2065431672 cites W2161844215 @default.
• W2065431672 cites W2441750859 @default.
• W2065431672 cites W3189918132 @default.
• W2065431672 doi "https://doi.org/10.1097/crd.0b013e3182137758" @default.
• W2065431672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21464643" @default.
• W2065431672 hasPublicationYear "2011" @default.
• W2065431672 type Work @default.
• W2065431672 sameAs 2065431672 @default.
• W2065431672 citedByCount "25" @default.
• W2065431672 countsByYear W20654316722012 @default.
• W2065431672 countsByYear W20654316722013 @default.
• W2065431672 countsByYear W20654316722014 @default.
• W2065431672 countsByYear W20654316722015 @default.
• W2065431672 countsByYear W20654316722017 @default.
• W2065431672 countsByYear W20654316722018 @default.
• W2065431672 countsByYear W20654316722021 @default.
• W2065431672 crossrefType "journal-article" @default.
• W2065431672 hasAuthorship W2065431672A5002697588 @default.
• W2065431672 hasAuthorship W2065431672A5009134798 @default.
• W2065431672 hasBestOaLocation W20654316721 @default.
• W2065431672 hasConcept C126322002 @default.
• W2065431672 hasConcept C177713679 @default.
• W2065431672 hasConcept C2776301958 @default.
• W2065431672 hasConcept C2777288759 @default.
• W2065431672 hasConcept C2778810321 @default.
• W2065431672 hasConcept C2779161974 @default.
• W2065431672 hasConcept C2780035454 @default.
• W2065431672 hasConcept C71924100 @default.
• W2065431672 hasConcept C98274493 @default.
• W2065431672 hasConceptScore W2065431672C126322002 @default.
• W2065431672 hasConceptScore W2065431672C177713679 @default.
• W2065431672 hasConceptScore W2065431672C2776301958 @default.
• W2065431672 hasConceptScore W2065431672C2777288759 @default.
• W2065431672 hasConceptScore W2065431672C2778810321 @default.
• W2065431672 hasConceptScore W2065431672C2779161974 @default.
• W2065431672 hasConceptScore W2065431672C2780035454 @default.
• W2065431672 hasConceptScore W2065431672C71924100 @default.
• W2065431672 hasConceptScore W2065431672C98274493 @default.
• W2065431672 hasIssue "3" @default.
• W2065431672 hasLocation W20654316721 @default.
• W2065431672 hasLocation W20654316722 @default.
• W2065431672 hasLocation W20654316723 @default.
• W2065431672 hasOpenAccess W2065431672 @default.
• W2065431672 hasPrimaryLocation W20654316721 @default.
• W2065431672 hasRelatedWork W1973989324 @default.
• W2065431672 hasRelatedWork W1994905407 @default.
• W2065431672 hasRelatedWork W2063976695 @default.
• W2065431672 hasRelatedWork W2108977729 @default.
• W2065431672 hasRelatedWork W2160502551 @default.
• W2065431672 hasRelatedWork W2161066565 @default.
• W2065431672 hasRelatedWork W2341835401 @default.
• W2065431672 hasRelatedWork W4254988178 @default.
• W2065431672 hasRelatedWork W1810372846 @default.
• W2065431672 hasRelatedWork W2344108540 @default.
• W2065431672 hasVolume "19" @default.
• W2065431672 isParatext "false" @default.
• W2065431672 isRetracted "false" @default.
• W2065431672 magId "2065431672" @default.
• W2065431672 workType "article" @default.